Back to Products
Rosuvastatin & Ezetimibe
Primary Hyperlipidemia: Rovius-EZ is indicated for the reduction of elevated total cholesterol (total-C), low density lipoprotein cholesterol (LDL-C), apolipoprotein B (Apo B), triglycerides (TG) and non-high density lipoprotein cholesterol (non-HDL-C).
Homozygous Familial Hypercholesterolemia: Rovius-EZ is indicated for the reduction of elevated total-C and LDL-C in patients with homozygous familial hypercholesterolemia, as an adjunct to other lipid-lowering treatments.
The dosage range of Rovius-EZ is 5/10 mg once daily to 40/10 mg once daily. The recommended starting dose of Rovius-EZ is 5/10 mg once daily or 10/10 mg once daily. Rovius-EZ can be administered as a single dose at any time of the day, with or without food. After initiation and/or upon titration of Rovius-EZ, lipid levels should be analyzed within 2 or more weeks and dosage adjusted accordingly.
Rovius-EZ 5/10 Tablet: Each box contains 30 tablets (3×10’s) in blister pack.
Rovius-EZ 10/10 Tablet: Each box contains 30 tablets (3×10’s) in blister pack.
